HAVCR2 and cancer: TIM-3 is sufficient to change the basic regulatory function of T reg cells, thereby studying how checkpoint therapies effect T reg in tumormicroenvironment and chronic infection may lead us to better Understanding the role of Tim-3 in Treg, and could contribute to novel therapeutic approaches for diseases such as cancer and chronic infection.